JPRN-UMIN000015463已完成2 期
Phase II trial of Transarterial Chemoembolization using Drug-eluting bead for advanced HCC refractory to Lipiodol-TACE - TALENT study
Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization0 个研究点目标入组 24 人开始时间: 2014年10月17日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) after HCC rupture 2) Reconstruction of the biliary tract history 3) severe ascites or pleural effusion 4) severe arterioportal shunt or arteriovenous shunt 5) Severe complication (Cardiac failure, Myocardial infarction, Pulmonary fibrosis, Interstitial pneumonia, Uncontrollable diabetic, Renal failure) 6) development of collateral feeding artery 7) Pregnant, nursing or possible pregnant woman 8) Heparic artery occlusion under CT angiography or angiography (Registration after qualification with CT angiography. Judging occlusion under angiography, including reservoir DAS, in case unqualified judgement with CT angiography) 9) Qualified ineligible patients being this clinical trial by responsible doctor
研究者
相似试验
进行中（未招募）
不适用
Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC) - TACE and sorafenib for HCChistologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCCMedDRA version: 9.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableEUCTR2007-000730-40-DEHeinrich-Heine-Universität Düsseldorf
已完成
2 期
Phase II study: Transcatheter Arterial Chemoembolization Therapy In Combination with Sorafenib (TACTICS)HCCJPRN-UMIN000004316Japan Liver Oncology Group228
已完成
1 期
Phase I study of transarterial chemoembolization using Cisplatin powder and miriplatin in patients with hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000010431Southern TOHOKU General Hospital10
已完成
2 期
PhaseII study of trancatheter arterial chemoembolizaion with miriplatin for hepatocellular carcinoma -Compared with retrospective historical cohort study with epirubicin hydrochlorideHepatocellular carcinomaJPRN-UMIN000005229ara Medical University, Department of Radiology33
已完成
不适用
A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)nresectable hypervascular hepatocellular carcinomaJPRN-C000000049Japan Interventional Radiology in Oncology Study Group (JIVROSG)60